EHTHMEDIUM SIGNALFINANCIAL10-K

EHTH showed strong revenue growth but operational cash flow deteriorated further into negative territory while the company strengthened its balance sheet liquidity position.

The company appears to be in a growth phase with meaningful revenue expansion, but the worsening operating cash flow suggests challenges in converting that growth into actual cash generation. The substantial increase in cash reserves provides a cushion, but investors should monitor whether the company can improve operational efficiency and cash conversion as it scales.

Comparing 2026-02-26 vs 2025-02-27View on EDGAR →
FINANCIAL ANALYSIS

EHTH delivered solid revenue growth of 46% while maintaining reasonable gross profit expansion of 16%, indicating the business model remains viable during scaling. However, operating cash flow deteriorated deeper into negative territory, moving from -$18.4M to -$25.3M, suggesting operational challenges in cash conversion. The company notably strengthened its liquidity position with cash roughly doubling to $73.7M, while accounts receivable declined substantially, providing financial flexibility during this growth phase.

FINANCIAL STATEMENT CHANGES
Cash & Equivalents
Balance Sheet
+88.1%
$39.2M→$73.7M

Cash position surged 88.1% — strong cash generation or capital raise providing significant financial cushion.

Accounts Receivable
Balance Sheet
-54.3%
$16.8M→$7.7M

Receivables declined — improved collection efficiency or conservative revenue recognition.

Revenue
P&L
+45.9%
$172.4M→$251.4M

Strong top-line growth of 45.9% — accelerating demand or successful expansion into new markets.

Interest Expense
P&L
+43.9%
$7.6M→$11.0M

Interest expense surged 43.9% — significant debt increase or rising rates materially impacting earnings.

Operating Cash Flow
Cash Flow
-38%
-$18.4M→-$25.3M

Operating cash flow fell 38% — earnings quality concerns; investigate working capital changes and non-cash items.

Total Liabilities
Balance Sheet
+25.9%
$229.5M→$288.8M

Liabilities increased 25.9% — monitor debt-to-equity ratio and interest coverage.

Gross Profit
P&L
+15.5%
$208.5M→$240.8M

Gross profit expanding — improving pricing power or product mix shift toward higher-margin offerings.

R&D Expense
P&L
+11.3%
$12.4M→$13.8M

R&D investment increased 11.3% — signals commitment to future product development, though near-term margin impact.

LANGUAGE CHANGES
NEW — 2026-02-26
PRIOR — 2025-02-27
ADDED
Investors should carefully consider the risks and uncertainties discussed under the caption Risk Factors and elsewhere in this Annual Report on Form 10-K before deciding whether to invest in our securities.
The following is a list of some of these risks: The markets in which we participate are intensely competitive.
Our marketing, brand promotion and consumer outreach efforts may be unsuccessful, increasingly costly, or limited by evolving technology, regulatory requirements or partner practices, which could adversely affect our business, operating results and financial condition.
Our business, operating results and financial condition may be impacted by factors that impact our constrained estimated lifetime value of commissions per approved member.
Our business may be harmed by any impairment of our relationships with them or impairment of their businesses.
+7 more — sign up free →
REMOVED
Any impairment of our relationships with them or impairment of their businesses could adversely affect our business, operating results and financial condition.
Our marketing efforts may not be successful or may become more expensive, either of which could adversely affect our business, operating results and financial condition.
Our operations in China involve many risks that could increase expenses, expose us to increased liability and adversely affect our business, operating results and financial condition.
From time to time we are subject to various legal proceedings, which could adversely affect our business, operating results and financial condition.
O ur business could be harmed if we are unable to contact our consumers or market the availability of our products through specific channels.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →